BVF INC/IL - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$76,936,000
+144.2%
2,078,220
+25.3%
3.18%
+108.8%
Q2 2022$31,509,000
-29.1%
1,659,220
+0.7%
1.52%
-14.4%
Q1 2022$44,463,000
+19.8%
1,647,4000.0%1.78%
+32.1%
Q4 2021$37,116,0001,647,4001.35%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders